Stéphanie Longet, PhD

16th Vaccine Congress (Elsevier) (12-14 septembre 2022, Lac de Garde, Italie): Stephanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca Brown, Hailey R Hornsby, Naomi Meardon, Tom Tipton, Eleanor Barnes, Susanna Dunachie, Christopher JA Duncan, Paul Klenerman, Alex Richter, Lance Turtle, Thushan I. de Silva^, Miles W. Carroll^ on behalf of the PITCH Consortium. “COVID-19 mRNA vaccination drives differential mucosal neutralising antibody profiles in naïve and SARS-CoV-2 previously infected individuals.”

​

Oxford Immunology Group Symposium 2022 (8 avril 2022, Oxford, Royaume-Uni): Stephanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca Brown, Hailey R Hornsby, Naomi Meardon, Tom Tipton, Eleanor Barnes, Susanna Dunachie, Christopher JA Duncan, Paul Klenerman, Alex Richter, Lance Turtle, Thushan I. de Silva^, Miles W. Carroll^ on behalf of the PITCH Consortium. “COVID-19 mRNA vaccination drives differential mucosal neutralising antibody profiles in naïve and SARS-CoV-2 previously infected individuals.”

​

British Society for Immunology Congress 2021 (28 novembre au 1er décembre 2021, Edimbourg, Royaume-Uni): Stephanie Longet, Rebecca Payne, Adrienn Angyal, Donal T. Skelly, Adam Harding, James A. Austin, Shona Moore, Tom Tipton, Alexander Hargreaves, Alexandra S. Deeks, Sarah L. Rowland-Jones, Eleanor Barnes, Chris Duncan, Lance Turtle, Alex Richter, Gavin Screaton, Paul Klenerman, Miles Carroll, Thushan I. de Silva, Susanna Dunachie on behalf of the PITCH consortium. “Impact of short or long dosing intervals on antibody responses to Pfizer/BNT vaccine.”

​

QuanTII Workshop 2019 (September 17 2019 in Leeds, UK): "Adaptive immune response to Ebola virus".

​

Immunology Research Forum 2018 (September 28 2018 in Dublin, Ireland): "Targeting iNKT cells for improved oral vaccination."

 

Mucosal Vaccines, Adjuvants and Delivery Systems Meeting 2017 (September 12-14 2017 in Porto, Portugal): Stephanie Longet, Christopher Davitt, Joshua Tobias, Jan Holmgren, Ed C Lavelle. "The oral adjuvant alpha-Galactosylceramide activates intestinal B cells via an IFN-gamma dependent mechanism."

​

Mucosal Vaccines, Adjuvants and Delivery Systems Meeting 2016 (September 14-16 2016 in Lausanne, Switzerland): Stephanie Longet, Christophe Davitt, Edel McNeela, Vincenzo Aversa, Joshua Tobias, Michael Lebens, Monica Rosa, Jan Holmgren, Ivan Coulter, Ed C Lavelle."A novel adjuvanted capsule based strategy for oral vaccination against enteric bacterial pathogens."

Irish Society Immunology Meeting 2015 (September 17-18, 2015 in Dublin, Ireland): Stephanie Longet, Christophe Davitt, Edel McNeela, Vincenzo Aversa, Joshua Tobias, Michael Lebens, Monica Rosa, Jan Holmgren, Ivan Coulter, Ed C Lavelle. "A novel adjuvanted capsule based strategy for oral vaccination against enteric bacterial pathogens."

2nd International E.coli and the Mucosal Immune System symposium (July 10-13, 2015 in Ghent, Belgium): Stephanie Longet, Christophe Davitt, Edel McNeela, Vincenzo Aversa, Joshua Tobias, Michael Lebens, Monica Rosa, Jan Holmgren, Ivan Coulter, Ed C Lavelle. “The novel oral vaccine delivery technology SmPill® significantly increases enterotoxigenic Escherichia coli vaccine specific-intestinal antibody responses”

“Vaccine For Enteric Diseases 2015” Meeting (July 8-10, 2015 in Edinburgh, UK): Stephanie Longet, Christophe Davitt, Edel McNeela, Vincenzo Aversa, Joshua Tobias, Michael Lebens, Monica Rosa, Jan Holmgren, Ivan Coulter, Ed C Lavelle. “The novel oral vaccine delivery technology SmPill® significantly increases vaccine specific-intestinal antibody responses”